• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Jing, HUO Meirong, ZHOU Jianping, ZHANG Yong, ZHANG Xuyuan, WANG Lei, YIN Tingjie. Drug-loaded micelles based on hyaluronic acid-paclitaxel prodrug: preparation and pharmacokinetic study in rats[J]. Journal of China Pharmaceutical University, 2013, 44(6): 520-525. DOI: 10.11665/j.issn.1000-5048.20130606
Citation: WANG Jing, HUO Meirong, ZHOU Jianping, ZHANG Yong, ZHANG Xuyuan, WANG Lei, YIN Tingjie. Drug-loaded micelles based on hyaluronic acid-paclitaxel prodrug: preparation and pharmacokinetic study in rats[J]. Journal of China Pharmaceutical University, 2013, 44(6): 520-525. DOI: 10.11665/j.issn.1000-5048.20130606
shu

Drug-loaded micelles based on hyaluronic acid-paclitaxel prodrug: preparation and pharmacokinetic study in rats

More Information
    Graphical Abstract
    • Abstract
  • The aims of this study were to prepare high paclitaxel loading amount polymeric micelles based on amphiphilic hyaluronic acid-paclitaxel prodrug. The drug-loading and entrapment efficiency were characterized by HPLC. The physico-chemical properties of PTX loaded HA-PTX micelles(PTX-HA-PTX)was characterized by dynamic light scattering(DLS), transmission electron microscope(TEM), atomic force microscopy(AFM)and X-ray diffraction(XRD), respectively. The critical micelle concentration(CMC)was determined by fluorescence pyrene probe techniques. The pharmacokinetics behaviors of PTX-HA-PTX micelles were performed in rats taking Taxol as control. It was found that the drug-loading and encapsulation efficiency of PTX-HA-PTX micelles reached up to 41. 8% and 95. 4%, respectively. The nanoparticle size was approximately 213. 2 nm and the Zeta potential was -15. 5 mV. PTX-HA-PTX micelles exhibited to be almost spherical in shape from the observation by TEM and AFM. XRD results confirmed that PTX was either molecularly dispersed in the polymers or distributed in the micelles in an amorphous state. In pharmacokinetic studies, the AUC value of PTX-HA-PTX micelles increased significantly(P< 0. 01)while the CL value decreased significantly(P< 0. 05)compared with Taxol, which indicated slower clearance rate, prolonged residence time and enhanced therapeutic effect. All the results demonstrated that PTX-HA-PTX micelles might be a promising PTX delivery carrier for efficient tumor therapy.
    • FullText(HTML)
    • References (19)
  • [1]
    Crown J,O′Leary M,Ooi WS.Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience[J].Oncologist,2004,9(Suppl 2):24-32.
    [2]
    Onetto N,Canetta R,Winograd B,et al.Overview of Taxol safety[J].J Natl Cancer Inst Monogr,1993(15):131-139.
    [3]
    Zhou J,Zhao WY,Ma X,et al.The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer[J].Biomaterials,2013,34(14):3 626-3 638.
    [4]
    Yang C,Wang J,Chen D,et al.Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-)CD34(-)tumor stem-like cells in multiple myeloma-bearing mice[J].Int J Nanomedicine,2013,8:1 439-1 449.
    [5]
    Takegami S,Takara K,Tanaka S,et al.Characterization,in vitro cytotoxicity and cellular accumulation of paclitaxel-loaded lipid nano-emulsions[J].J Microencapsul,2010,27(5):453-459.
    [6]
    Nornoo AO,Chow DS.Cremophor-free intravenous microemulsions for paclitaxel II.Stability,in vitro release and pharmacokinetics[J].Int J Pharm,2008,349(1/2):117-123.
    [7]
    Okamatsu A, Motoyama K, Onodera R, et al. Folate-appended beta-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo[J].Bioconjug Chem,2013,24(4):724-733.
    [8]
    Pan Z,Gao Y,Heng L,et al.Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery[J].Carbohydr Polym,2013,94(1):394-399.
    [9]
    Li J,Huo M,Wang J,et al.Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel[J].Biomaterials,2012,33(7):2 310-2 320.
    [10]
    Zhang X,Lu J,Huang Y,et al.PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel[J].Bioconjug Chem,2013,24(3):464-472.
    [11]
    Ye Q,Huo MR,Zhou JP.Pharmacokinetics and in situ absorption in rat intestine of paclitaxel-loaded amphiphilic chitosan micelle[J].J China Pharm Univ(中国药科大学学报),2012,43(5):401-405.
    [12]
    Nam K,Nam HY,Kim PH,et al.Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly(disulfide amine)micelles for co-delivery of drug and gene[J].Biomaterials,2012,33(32):8 122-8 130.
    [13]
    Wang Y,Xin D,Liu K,et al.Heparin-paclitaxel conjugates as drug delivery system: synthesis,self-assembly property,drug release,and antitumor activity[J].Bioconjug Chem,2009,20(12):2 214-2 221.
    [14]
    Zou AF,Huo MR,Zhou JP,et al.Octreotide-mediated N-octyl-O,N-carboxymethyl chitosan micelles:preparation,characterization and research as doxorubicin delivery vectors[J].J China Pharm Univ(中国药科大学学报),2011,42(2):124-130.
    [15]
    Gaucher G, Marchessault RH, Leroux JC. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes[J].J Control Release,2010,143(1):2-12.
    [16]
    Oh EJ,Park K,Kim KS,et al.Target specific and long-acting delivery of protein,peptide,and nucleotide therapeutics using hyaluronic acid derivatives[J].J Control Release,2010,141(1):2-12.
    [17]
    Zhang Y,Huo M,Zhou J,et al.PKSolver:an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel[J].Comput Methods Programs Biomed,2010,99(3):306-314.
    [18]
    Huo M,Zhang Y,Zhou J,et al.Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug[J].Int J Pharm,2010,394(1/2):162-173.
    [19]
    Stylianopoulos T.EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors[J].Ther Deliv,2013,4(4):421-423.
    • Related Articles

  • Related Articles

    [1]YANG Ruocong, DUAN Feipeng, CHAO Jiahong, TIAN Pengpeng, YAN Zhiyong, LI Shaojing. Advances of microRNA activity in innate immunity[J]. Journal of China Pharmaceutical University, 2017, 48(4): 396-406. DOI: 10.11665/j.issn.1000-5048.20170403
    [2]SI Lianghui, MA Hui, ZHOU Jinpei, ZHANG Huibin. Advances in antidiabetic small molecule ABHD6 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(2): 125-134. DOI: 10.11665/j.issn.1000-5048.20170201
    [3]WU Shiwei, ZHANG Hui, LI Qianbin, HU Gaoyun. Advances in thioredoxin reductase and its inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 511-520. DOI: 10.11665/j.issn.1000-5048.20160502
    [4]XIN Minhang, ZHANG Sanqi. Advances in PI3Kδ selective inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 503-510. DOI: 10.11665/j.issn.1000-5048.20160501
    [5]YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417
    [6]LIU Kejun, ZHANG Zhimin, RAN Ting, CHEN Hongli, LU Tao, CHEN Yadong. Advances in BET bromodomain protein inhibitors[J]. Journal of China Pharmaceutical University, 2015, 46(3): 264-271. DOI: 10.11665/j.issn.1000-5048.20150302
    [7]LI Tonghui, GUO Hao, LU Tao, WANG Yue, LU Shuai, TANG Weifang. Advances in the research of FLT3 inhibitors for acute myeloid leukemia[J]. Journal of China Pharmaceutical University, 2015, 46(2): 153-161. DOI: 10.11665/j.issn.1000-5048.20150203
    [8]LI Chunhong, DU Hongjin, WEN Xiao′an, SUN Hongbin. Advances in inhibitors of MDM2 and MDM4[J]. Journal of China Pharmaceutical University, 2015, 46(1): 1-15. DOI: 10.11665/j.issn.1000-5048.20150101
    [9]Advances in the research of factor Xa inhibitors[J]. Journal of China Pharmaceutical University, 2010, 41(2): 104-111.
    [10]Advances in Selective COX-2 Inhibitors[J]. Journal of China Pharmaceutical University, 2003, (3): 1-6.

Catalog

    Get Citation
    PDF
    XML
    Article views (1871) PDF downloads (3627) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：292743

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return